Migraine Diagnosis and Classification-Pharmacologic Approach to Migraine Treatment

Video Transcription

Video Summary

Dr. Brittany Mays from Vanderbilt University Medical Center presents a comprehensive lecture on pharmacologic approaches to migraine treatment, emphasizing a two-pronged approach: preventive and acute treatments. Preventive treatments aim to reduce frequency and intensity of migraines, akin to a defensive line in soccer. Acute treatments, compared to a goalie, address breakthrough migraines and are used sparingly to avoid medication overuse headaches. Dr. Mays advocates for starting preventive treatments for patients experiencing over four migraine days per month. Key preventive medications include beta blockers, tricyclic antidepressants (TCAs), and anticonvulsants like topiramate. Newer CGRP antagonists and onabotulinum toxin A (Botox) show promise as second-line options. Acute treatments mainly involve triptans, NSAIDs, and antiemetics, with newer alternatives like CGRP antagonists for patients unsuited for triptans. Special considerations for pregnant or lactating women include the use of propranolol, magnesium, and exploring non-pharmacologic treatments. Dr. Mays stresses the importance of individualized treatment plans, monitoring efficacy, adverse effects, and avoiding medication overuse. Lastly, stay tuned for upcoming lectures on non-pharmacologic migraine treatments.

Keywords

migraine treatment

preventive treatments

acute treatments

pharmacologic approaches

CGRP antagonists

individualized treatment

medication overuse